NEW YORK,Oct. 26 (GenomeWeb News) - Shares in CombiMatrix were up 79.7 percent, or $1.10, at $2.48 in mid-afternoon trading after the company launched an influenza DNA microarray.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.